2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: To develop and validate new classification criteria for Takayasu arteritis (TAK).
METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in six phases: (1) identification of candidate criteria items, (2) collection of candidate items present at diagnosis, (3) expert panel review of cases, (4) data-driven reduction of candidate items, (5) derivation of a points-based classification score in a development data set and (6) validation in an independent data set.
RESULTS: The development data set consisted of 316 cases of TAK and 323 comparators. The validation data set consisted of an additional 146 cases of TAK and 127 comparators. Age ≤60 years at diagnosis and imaging evidence of large-vessel vasculitis were absolute requirements to classify a patient as having TAK. The final criteria items and weights were as follows: female sex (+1), angina (+2), limb claudication (+2), arterial bruit (+2), reduced upper extremity pulse (+2), reduced pulse or tenderness of a carotid artery (+2), blood pressure difference between arms of ≥20 mm Hg (+1), number of affected arterial territories (+1 to +3), paired artery involvement (+1) and abdominal aorta plus renal or mesenteric involvement (+3). A patient could be classified as having TAK with a cumulative score of ≥5 points. When these criteria were tested in the validation data set, the model area under the curve was 0.97 (95% CI 0.94 to 0.99) with a sensitivity of 93.8% (95% CI 88.6% to 97.1%) and specificity of 99.2% (95% CI 96.7% to 100.0%).
CONCLUSION: The 2022 American College of Rheumatology/EULAR classification criteria for TAK are now validated for use in research.
Errataetall: |
CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1074. - PMID 36637733 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
Annals of the rheumatic diseases - 81(2022), 12 vom: 27. Dez., Seite 1654-1660 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Grayson, Peter C [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autoimmune Diseases |
---|
Anmerkungen: |
Date Completed 14.11.2022 Date Revised 06.06.2023 published: Print-Electronic CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1074. - PMID 36637733 Citation Status MEDLINE |
---|
doi: |
10.1136/ard-2022-223482 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348653271 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348653271 | ||
003 | DE-627 | ||
005 | 20231226040754.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/ard-2022-223482 |2 doi | |
028 | 5 | 2 | |a pubmed24n1162.xml |
035 | |a (DE-627)NLM348653271 | ||
035 | |a (NLM)36351705 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Grayson, Peter C |e verfasserin |4 aut | |
245 | 1 | 0 | |a 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.11.2022 | ||
500 | |a Date Revised 06.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1074. - PMID 36637733 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVE: To develop and validate new classification criteria for Takayasu arteritis (TAK) | ||
520 | |a METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in six phases: (1) identification of candidate criteria items, (2) collection of candidate items present at diagnosis, (3) expert panel review of cases, (4) data-driven reduction of candidate items, (5) derivation of a points-based classification score in a development data set and (6) validation in an independent data set | ||
520 | |a RESULTS: The development data set consisted of 316 cases of TAK and 323 comparators. The validation data set consisted of an additional 146 cases of TAK and 127 comparators. Age ≤60 years at diagnosis and imaging evidence of large-vessel vasculitis were absolute requirements to classify a patient as having TAK. The final criteria items and weights were as follows: female sex (+1), angina (+2), limb claudication (+2), arterial bruit (+2), reduced upper extremity pulse (+2), reduced pulse or tenderness of a carotid artery (+2), blood pressure difference between arms of ≥20 mm Hg (+1), number of affected arterial territories (+1 to +3), paired artery involvement (+1) and abdominal aorta plus renal or mesenteric involvement (+3). A patient could be classified as having TAK with a cumulative score of ≥5 points. When these criteria were tested in the validation data set, the model area under the curve was 0.97 (95% CI 0.94 to 0.99) with a sensitivity of 93.8% (95% CI 88.6% to 97.1%) and specificity of 99.2% (95% CI 96.7% to 100.0%) | ||
520 | |a CONCLUSION: The 2022 American College of Rheumatology/EULAR classification criteria for TAK are now validated for use in research | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Autoimmune Diseases | |
650 | 4 | |a Behcet Syndrome | |
650 | 4 | |a Cardiovascular Diseases | |
700 | 1 | |a Ponte, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Suppiah, Ravi |e verfasserin |4 aut | |
700 | 1 | |a Robson, Joanna C |e verfasserin |4 aut | |
700 | 1 | |a Gribbons, Katherine Bates |e verfasserin |4 aut | |
700 | 1 | |a Judge, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Craven, Anthea |e verfasserin |4 aut | |
700 | 1 | |a Khalid, Sara |e verfasserin |4 aut | |
700 | 1 | |a Hutchings, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Danda, Debashish |e verfasserin |4 aut | |
700 | 1 | |a Luqmani, Raashid A |e verfasserin |4 aut | |
700 | 1 | |a Watts, Richard A |e verfasserin |4 aut | |
700 | 1 | |a Merkel, Peter A |e verfasserin |4 aut | |
700 | 0 | |a DCVAS Study Group |e verfasserin |4 aut | |
700 | 1 | |a Gatenby, Paul |e investigator |4 oth | |
700 | 1 | |a Hill, Catherine |e investigator |4 oth | |
700 | 1 | |a Ranganathan, Dwarakanathan |e investigator |4 oth | |
700 | 1 | |a Kronbichler, Andreas |e investigator |4 oth | |
700 | 1 | |a Blockmans, Daniel |e investigator |4 oth | |
700 | 1 | |a Barra, Lillian |e investigator |4 oth | |
700 | 1 | |a Carette, Simon |e investigator |4 oth | |
700 | 1 | |a Pagnoux, Christian |e investigator |4 oth | |
700 | 1 | |a Dhindsa, Navjot |e investigator |4 oth | |
700 | 1 | |a Fifi-Mah, Aurore |e investigator |4 oth | |
700 | 1 | |a Khalidi, Nader |e investigator |4 oth | |
700 | 1 | |a Liang, Patrick |e investigator |4 oth | |
700 | 1 | |a Milman, Nataliya |e investigator |4 oth | |
700 | 1 | |a Pineau, Christian |e investigator |4 oth | |
700 | 1 | |a Tian, Xinping |e investigator |4 oth | |
700 | 1 | |a Wang, Guochun |e investigator |4 oth | |
700 | 1 | |a Wang, Tian |e investigator |4 oth | |
700 | 1 | |a Zhao, Ming-Hui |e investigator |4 oth | |
700 | 1 | |a Tesar, Vladimir |e investigator |4 oth | |
700 | 1 | |a Baslund, Bo |e investigator |4 oth | |
700 | 1 | |a Hammam, Nevin |e investigator |4 oth | |
700 | 1 | |a Shahin, Amira |e investigator |4 oth | |
700 | 1 | |a Pirila, Laura |e investigator |4 oth | |
700 | 1 | |a Putaala, Jukka |e investigator |4 oth | |
700 | 1 | |a Hellmich, Bernhard |e investigator |4 oth | |
700 | 1 | |a Henes, Jörg |e investigator |4 oth | |
700 | 1 | |a Holle, Julia |e investigator |4 oth | |
700 | 1 | |a Moosig, Frank |e investigator |4 oth | |
700 | 1 | |a Lamprecht, Peter |e investigator |4 oth | |
700 | 1 | |a Neumann, Thomas |e investigator |4 oth | |
700 | 1 | |a Schmidt, Wolfgang |e investigator |4 oth | |
700 | 1 | |a Sunderkoetter, Cord |e investigator |4 oth | |
700 | 1 | |a Szekanecz, Zoltan |e investigator |4 oth | |
700 | 1 | |a Danda, Debashish |e investigator |4 oth | |
700 | 1 | |a Das, Siddharth |e investigator |4 oth | |
700 | 1 | |a Gupta, Rajiva |e investigator |4 oth | |
700 | 1 | |a Rajasekhar, Liza |e investigator |4 oth | |
700 | 1 | |a Sharma, Aman |e investigator |4 oth | |
700 | 1 | |a Wagh, Shrikant |e investigator |4 oth | |
700 | 1 | |a Clarkson, Michael |e investigator |4 oth | |
700 | 1 | |a Molloy, Eamonn |e investigator |4 oth | |
700 | 1 | |a Salvarani, Carlo |e investigator |4 oth | |
700 | 1 | |a Schiavon, Franco |e investigator |4 oth | |
700 | 1 | |a Tombetti, Enrico |e investigator |4 oth | |
700 | 1 | |a Vaglio, Augusto |e investigator |4 oth | |
700 | 1 | |a Amano, Koichi |e investigator |4 oth | |
700 | 1 | |a Arimura, Yoshihiro |e investigator |4 oth | |
700 | 1 | |a Dobashi, Hiroaki |e investigator |4 oth | |
700 | 1 | |a Fujimoto, Shouichi |e investigator |4 oth | |
700 | 1 | |a Harigai, Masayoshi |e investigator |4 oth | |
700 | 1 | |a Hirano, Fumio |e investigator |4 oth | |
700 | 1 | |a Hirahashi, Junichi |e investigator |4 oth | |
700 | 1 | |a Honma, Sakae |e investigator |4 oth | |
700 | 1 | |a Kawakami, Tamihiro |e investigator |4 oth | |
700 | 1 | |a Kobayashi, Shigeto |e investigator |4 oth | |
700 | 1 | |a Kono, Hajime |e investigator |4 oth | |
700 | 1 | |a Makino, Hirofumi |e investigator |4 oth | |
700 | 1 | |a Matsui, Kazuo |e investigator |4 oth | |
700 | 1 | |a Muso, Eri |e investigator |4 oth | |
700 | 1 | |a Suzuki, Kazuo |e investigator |4 oth | |
700 | 1 | |a Ikeda, Kei |e investigator |4 oth | |
700 | 1 | |a Takeuchi, Tsutomu |e investigator |4 oth | |
700 | 1 | |a Tsukamoto, Tatsuo |e investigator |4 oth | |
700 | 1 | |a Uchida, Shunya |e investigator |4 oth | |
700 | 1 | |a Wada, Takashi |e investigator |4 oth | |
700 | 1 | |a Yamada, Hidehiro |e investigator |4 oth | |
700 | 1 | |a Yamagata, Kunihiro |e investigator |4 oth | |
700 | 1 | |a Yumura, Wako |e investigator |4 oth | |
700 | 1 | |a Lai, Kan Sow |e investigator |4 oth | |
700 | 1 | |a Flores-Suarez, Luis Felipe |e investigator |4 oth | |
700 | 1 | |a Hinojosa-Azaola, Andrea |e investigator |4 oth | |
700 | 1 | |a Rutgers, Bram |e investigator |4 oth | |
700 | 1 | |a Tak, Paul-Peter |e investigator |4 oth | |
700 | 1 | |a Grainger, Rebecca |e investigator |4 oth | |
700 | 1 | |a Quincey, Vicki |e investigator |4 oth | |
700 | 1 | |a Stamp, Lisa |e investigator |4 oth | |
700 | 1 | |a Suppiah, Ravi |e investigator |4 oth | |
700 | 1 | |a Besada, Emilio |e investigator |4 oth | |
700 | 1 | |a Diamantopoulos, Andreas |e investigator |4 oth | |
700 | 1 | |a Sznajd, Jan |e investigator |4 oth | |
700 | 1 | |a Azevedo, Elsa |e investigator |4 oth | |
700 | 1 | |a Geraldes, Ruth |e investigator |4 oth | |
700 | 1 | |a Rodrigues, Miguel |e investigator |4 oth | |
700 | 1 | |a Santos, Ernestina |e investigator |4 oth | |
700 | 1 | |a Song, Yeong-Wook |e investigator |4 oth | |
700 | 1 | |a Moiseev, Sergey |e investigator |4 oth | |
700 | 1 | |a Hocevar, Alojzija |e investigator |4 oth | |
700 | 1 | |a Cid, Maria Cinta |e investigator |4 oth | |
700 | 1 | |a Moreno, Xavier Solanich |e investigator |4 oth | |
700 | 1 | |a Atukorala, Inoshi |e investigator |4 oth | |
700 | 1 | |a Berglin, Ewa |e investigator |4 oth | |
700 | 1 | |a Mohammed, Aladdin |e investigator |4 oth | |
700 | 1 | |a Segelmark, Mårten |e investigator |4 oth | |
700 | 1 | |a Daikeler, Thomas |e investigator |4 oth | |
700 | 1 | |a Direskeneli, Haner |e investigator |4 oth | |
700 | 1 | |a Hatemi, Gulen |e investigator |4 oth | |
700 | 1 | |a Kamali, Sevil |e investigator |4 oth | |
700 | 1 | |a Karadag, Ömer |e investigator |4 oth | |
700 | 1 | |a Pehlevan, Seval |e investigator |4 oth | |
700 | 1 | |a Adler, Matthew |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 81(2022), 12 vom: 27. Dez., Seite 1654-1660 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2022 |g number:12 |g day:27 |g month:12 |g pages:1654-1660 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2022-223482 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2022 |e 12 |b 27 |c 12 |h 1654-1660 |